- Home
- Case Register
- Public Consultations
- Closed - Mergers and Other Notifications
- Proposed Merger between GSK Trading Services Limited and UCB SA
Proposed Merger between GSK Trading Services Limited and UCB SA
13 February 2009
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Reference: | 400/002/09 |
---|---|
Notifying Parties: | GSK Trading Services Limited and UCB SA |
Notifying Date: | 13 February 2009 |
Summary of transaction: | PART 5 1. The Applicants This notification is made jointly by the acquiring party, GSK Trading Services Limited (“GSK”) and the vendor, UCB SA (“UCB”), (collectively, the “Parties”). 2. Description of the merger This notification is in relation to the acquisition by GSK of certain rights to distribute and market selected pharmaceutical products in certain emerging markets from UCB, including Singapore. In Singapore, GSK is also acquiring UCB’s local subsidiary. The Parties submit that given the large number of major players in the Singaporean market, availability of substitute products such as generic drugs, countervailing buyer power, competitive tender process for supply, and other competitive constraints in the relevant markets, the acquisition, when carried into effect, will not result in a substantial lessening of competition. 3. Relevant good(s) or service(s) involved The supply of pharmaceutical products in Singapore. |
Decision: | The proposed acquisition, if carried into effect, will not infringe the section 54 prohibition. |
Decision Date: | 23 March 2009 |